Product Information
LATANOPROST 0.005% EYE DROPS is a generic product labeled by Rising Pharma Holdings Inc., priced at $1.5751 per ML under NDC 64980051625. Its NADAC has been published 401 times since May 9, 2018.
FDA first approved this application on Apr 22, 2016. Its Orange Book therapeutic-equivalence code is AT.
Strength
50 ug/mL
Manufacturer
Rising Pharma Holdings Inc.NDC
64980051625
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
LATANOPROSTApproval Type
Generic (ANDA)
FDA Application
ANDA202442FDA Approved
4/22/2016
TE Code
AT
On Market Since
9/1/2016
Price Statistics
The NADAC for LATANOPROST 0.005% EYE DROPS has been published 401 times since May 9, 2018, and over the history we have for it it has declined 19.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5751 per ML |
|---|---|
| All-time high | $2.3880 (Sep 11, 2019) |
| All-time low | $1.4484 (Jul 17, 2024) |
| 52-week high | $1.8338 |
| 52-week low | $1.5685 |
| Median price | $1.8804 |
| Average price | $1.9139 |
| Largest weekly change | +22.2% (Aug 21, 2024) |
| Weeks tracked | 401 |
| Tracking since | May 9, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the latanoprost market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
latanoprost market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LATANOPROST 0.005% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for LATANOPROST 0.005% EYE DROPS, manufactured by Rising Pharma Holdings Inc., is $1.5751 per ML (NDC 64980051625), effective Sep 30, 2026.
How has the price of LATANOPROST 0.005% EYE DROPS changed over time?
Over the history we have for it, the NADAC for LATANOPROST 0.005% EYE DROPS has declined 19.5%. It has been tracked across 401 weekly CMS publications since May 9, 2018.
What are the highest and lowest recorded NADAC prices for LATANOPROST 0.005% EYE DROPS?
Since May 9, 2018, the NADAC for LATANOPROST 0.005% EYE DROPS has ranged from a low of $1.4484 (Jul 17, 2024) to a high of $2.3880 (Sep 11, 2019), with a median of $1.8804 per ML.
Are there cheaper alternatives to LATANOPROST 0.005% EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of LATANOPROST 0.005% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LATANOPROST 0.005% EYE DROPS?
LATANOPROST 0.005% EYE DROPS (NDC 64980051625) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.